newsfilter
← Latest News
Business Wire·

Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival

Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced a newly published